Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.
Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check48 days agoChange DetectedThe website has removed the 'Last Update Posted (Estimated)' and added a new 'Last Update Posted' feature.SummaryDifference0.0%
- Check49 days agoChange DetectedThe website has updated its status to 'Completed' with a new last update posted date of '2024-07-24', while removing previous entries indicating 'Active, not recruiting' and various estimated dates.SummaryDifference0.9%
- Check50 days agoChange DetectedThe study has been updated to version v2.10.0, with 5 locations now included, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.